Zai Lab Limited Share Price Hong Kong S.E.
Stocks
9688
KYG9887T1168
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.61 HKD | +3.26% |
|
+5.10% | -0.29% |
| 10/06 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
| 09/06 | Zai Lab Says China Approves Tivdak for Cervical Cancer Treatment | MT |
| Market Cap | 191.79Cr 1.5TCr 165.65Cr 152.65Cr 142.88Cr 267.77Cr 18TCr 271.92Cr 1.8TCr 702.74Cr 8.87TCr 719.79Cr 704.46Cr 31TCr | P/E Ratio 2026 * |
-7.71x | P/E Ratio 2027 * | -9.15x |
|---|---|---|---|---|---|
| Enterprise Value | 147.48Cr 1.16TCr 127.38Cr 117.38Cr 109.87Cr 205.9Cr 14TCr 209.09Cr 1.39TCr 540.37Cr 6.82TCr 553.48Cr 541.7Cr 24TCr | EV / Sales 2026 * |
3.29x | EV / Sales 2027 * | 2.57x |
| Free-Float |
95.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zai Lab Limited
| 1 day | +3.26% | ||
| 1 week | +5.10% | ||
| Current month | -2.16% | ||
| 1 month | -15.41% | ||
| 3 months | -6.78% | ||
| 6 months | -1.23% | ||
| Current year | -0.29% |
| 1 week | 12.52 |  | 13.84 |
| 1 month | 12.49 | | 15.98 |
| Current year | 12.31 | | 20.42 |
| 1 year | 12.31 | | 33.6 |
| 3 years | 10.56 | | 35.5 |
| 5 years | 10.56 | | 142 |
| 10 years | 10.56 | | 151.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 60 | 01/04/2014 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 07/07/2023 |
Rafael Amado
PSD | President | 62 | 01/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 60 | 01/04/2014 |
John Diekman
BRD | Director/Board Member | 82 | 01/01/2017 |
Peter Wirth
BRD | Director/Board Member | 74 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.26% | +5.10% | - | - | 191.79Cr | |
| +0.11% | -3.67% | +15.66% | -20.62% | 6.23TCr | |
| +1.44% | +5.33% | +68.19% | +227.50% | 6.06TCr | |
| +0.70% | +29.50% | +29.50% | +29.50% | 3.95TCr | |
| -0.84% | +7.11% | -55.44% | -61.88% | 3.68TCr | |
| +0.05% | +2.41% | +53.12% | -33.31% | 2.95TCr | |
| +0.65% | +6.01% | +60.19% | +76.64% | 2.17TCr | |
| +0.54% | +5.21% | +87.14% | -60.40% | 1.98TCr | |
| +0.78% | +5.19% | -4.05% | +126.95% | 1.7TCr | |
| +0.18% | -1.66% | +54.11% | +95.72% | 1.62TCr | |
| Average | +0.68% | +3.05% | +34.27% | +42.23% | 3.37TCr | |
| Weighted average by Cap. | +0.45% | +2.95% | +31.77% | +48.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45Cr 351.59Cr 39Cr 36Cr 33Cr 63Cr 4.26TCr 64Cr 421.67Cr 164.41Cr 2.08TCr 168.39Cr 164.81Cr 7.19TCr | 60Cr 466.69Cr 51Cr 47Cr 44Cr 83Cr 5.66TCr 84Cr 559.71Cr 218.22Cr 2.76TCr 223.52Cr 218.76Cr 9.54TCr |
| Net income | -24Cr -188.77Cr -21Cr -19Cr -18Cr -34Cr -2.29TCr -34Cr -226.39Cr -88Cr -1.11TCr -90Cr -88Cr -3.86TCr | -16Cr -122.61Cr -14Cr -12Cr -12Cr -22Cr -1.49TCr -22Cr -147.05Cr -57Cr -723.9Cr -59Cr -57Cr -2.51TCr |
| Net Debt | -44Cr -347.23Cr -38Cr -35Cr -33Cr -62Cr -4.21TCr -63Cr -416.44Cr -162.37Cr -2.05TCr -166.31Cr -162.77Cr -7.1TCr | -39Cr -303.4Cr -33Cr -31Cr -29Cr -54Cr -3.68TCr -55Cr -363.87Cr -141.87Cr -1.79TCr -145.31Cr -142.22Cr -6.2TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 13.61 $ | +3.26% | 35,67,500 |
| 12/26/12 | 13.18 $ | -1.27% | 2,69,55,160 |
| 11/26/11 | 13.35 $ | +0.68% | 1,31,00,700 |
| 10/26/10 | 13.26 $ | +5.57% | 1,57,75,900 |
| 09/26/09 | 12.56 $ | -3.01% | 1,21,43,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZLAB Stock
- 9688 Stock
Select your edition
All financial news and data tailored to specific country editions
